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Abstract 
The present study focussed on the quantitative estimation of in vitro antibacterial 
activity of aqueous extracts of fruits, stem, root, leaves and seeds of Emblica officinalis 
against Gram-positive versus Gram-negative bacteria. The study employed Staphylococcus 
aureus and Escherichia coli, respectively, as the test organisms and the assay was carried out 
by using agar well diffusion method. S. aureus was more susceptible to the extracts of fruits, 
stem, leaves and seeds of Emblica. The aqueous extract of leaves maximally inhibited the 
growth of S. aureus at its minimum concentration (0.1 µg) when compared to E. coli (1.0 
µg). MIC for fruit and seed extracts were 1.5 and 3.75 µg and 1.5 and 5.0 µg, respectively, 
for S. aureus and E. coli.  The aqueous extract of stem had the least activity where more 
quantities of the extract were required to inhibit the growth of both S. aureus (15.0 µg) and E. 
coli (20.0 µg). Both the test organisms were resistant to the aqueous extracts of root of 
Emblica officinalis. It could be attributed from the present study that the inhibitory effect of 
Emblica officinalis is more against Gram-positive than Gram-negative bacteria. The leaf of 
Emblica is more inhibitory to the growth of bacteria than fruits, seeds or stem. 
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Introduction: 
Medicinal plants contain wide 
array of bioactive compounds or 
phytochemicals that are extensively used 
as antimicrobial agents and 
chemotherapeutic agents. The bioactive 
compounds in these plants are effective 
therapeutics, devoid of any toxic or other 
adverse side effects (1). ‘Green medicine’, 
obtained from medicinal plants, has high 
curative potential and is being advocated 
now a day as dependable therapeutic aid 
than the costly synthetic drugs (2). 
Emblica officinalis Gaertn. is an Indian 
medicinal plant, extensively used in 
Ayurvedic and Unani systems of medicine 
(3). In spite of the slow recovery process, 
Emblica officinalis is more popular 
because of their low resistance in 
microorganisms and lesser side effects (4).  
Emblica officinals or Indian 
gooseberry, (Synonym Phyllanthus 
emblica Linn.; commonly known as Amla, 
Nelli and Amalaki) belongs to the family 
Euphorbiaceae (5). The fruits of E. 
officinalis are widely used in many of the 
Ayurvedic medicinal preparations such as 
kashayam, lehyam and arishtam. The 
species is native to India, though it grows 
well in tropical and sub-tropical regions of 
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Pakistan, Uzbekistan, Srilanka, South East 
Asia, China and Malaysia (6). E. 
officinalis is one among the three 
constituents of tribhala, a rejuvenating 
medicinal formula, popular for its 
effectiveness in the treatment of intestinal 
disorders, fever, cough and eye diseases 
(5). Two varieties of Emblica have been 
reported worldwide, the wild ones with 
smaller fruits and the cultivated ones or the 
‘Banarasi’ variety, with larger fruits (7). 
The plant E. officinalis is known for its 
digestion power, improving liver functions 
and is liver protective (2). It is a very good 
purifier of blood which in turn improves 
the health of liver by keeping the toxins 
and infections away. It has anti-viral, anti- 
bacterial, anti-cancer, anti-allergic, and 
anti-mutagenic properties (2). Fruits are 
reported as anti-inflammatory, analgesic 
and anti-pyretic (8, 9). Amla is the prime 
ingredient in most of the herbal medicines 
for skin ailments.  
E. officinalis is a small to medium 
sized deciduous tree, 8-15 meters tall, 
having thin light grey bark that exfoliates 
in small thin irregular flakes. The leaves 
are simple, sub-sessile, closely set along 
the branchlets and light green in colour, 
having the appearance of pinnate leaves. 
Flowers are greenish yellow, in axillary 
fascicles, unisexual, actinomorphic and 
trimerous. Male flowers are numerous on 
short slender pedicel. The female flowers 
are few, sub-sessile, pistillate, hypogynous 
and the ovary three celled (2). Fruits are 
globose, fleshy, pale yellow in colour, with 
six obscure vertical furrows enclosing six 
trigonous seeds.  
Extracts of various parts of E. 
officinalis such as leaves, stem, root, seeds 
and fruits have been widely used in 
treatment of various diseases. Several of 
the bioactive compounds in E. officinalis 
have been identified which includes the 
flavonoids (quercetin), ascorbic acid, gallic 
acid, alkaloids (phyllantine, phyllantidine), 
hydrolysable tannins (emblicanin A and 
B), punigluconin and pedunculagin (10, 1, 
7). The fruits of E. officinalis are rich in 
anti oxidants, contributed by the tannins 
and flavonoids contained in them (1). They 
are also the natural source of vitamin C. In 
this study attempts were made to assay the 
in vitro antibacterial activity of extracts of 
whole plant parts (fruits, seed, stem, root 
and leaves) of E. officinalis against E coli 
and S. aureus, thereby trying to compare 
their bactericidal activity against Gram-
positive and Gram-negative bacteria. 
 
Materials and Methods 
Collection of Sample 
Fruits, seeds, stem, roots and 
leaves of small variety of Emblica were 
collected from Kottayam and 
Pathanamthitta districts, Kerala, India.  
 
Bacterial Stains Used 
Bacterial cultures used in this study 
were obtained from the culture collections 
of School of Biosciences, Mahatma 
Gandhi University, Kottayam, Kerala, 
India.  Bacterial cultures namely 
Staphylococcus aureus and E. coli were 
included in this study as representatives of 
Gram-positive and Gram-negative group 
of bacteria. The bacterial strains were 
maintained on Nutrient Agar (HiMedia, 
India) plates or slants and were stored at 4 
°C before use. 
 
Surface Cleaning and Sterilization of 
the Samples 
In this study the various samples 
were surface sterilized following the 
modified procedure of Aneja (11). The 
samples namely fruits, stem, root, seeds 
and leaves were washed in running tap 
water for 10 minutes followed by detergent 
wash in 10 % Extran (Merck, India) for 10 
minutes. The samples were then rinsed 
with distilled water and cut into small 
pieces using a sterile scalpel. The cut 
pieces were rinsed in 70 % ethanol for 30 
seconds and washed again in distilled 
water till the ethanol smell completely 
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diminished. These were spread out in clean 
trays for oven drying. 
 
Preparation of Extracts  
A comparative assay of extracts of 
fruits, stem, root, seeds and leaves of 
Emblica was carried out in this study. The 
cleaned and cut samples of E. officinalis 
were oven dried at 60 °C, continuously, for 
7 days. The dried samples were dried and 
powdered using a clean grinder. The 
powder was stored in air sealed containers 
at room temperature before extraction. A 
fixed weight of 30 gm of each powdered 
material was weighed out in aseptic 
condition and was extracted with distilled 
water using the Soxhlet Apparatus at a 
temperature of 100 °C, respectively. The 
Soxhlet extraction was carried out 
continuously for 8 hrs. Each extract was 
concentrated by evaporation and made up 
to a final volume of 20 ml. The extracts 
were stored at room temperature, in sterile 
screw capped containers, till use. 
 
Determination of Antimicrobial Activity 
Preparation of Bacterial Suspension 
Pure isolated colonies of the E. coli 
and S. aureus were inoculated into 1 % 
peptone water and incubated at 37 °C for 
48 h and were used as inoculum for lawn 
culture on Mueller Hinton Agar (HiMedia, 
India).  
 
Antimicrobial Assay by Well Diffusion 
Assay 
A comparative, rather, quantitative 
assay was carried out using the suitable 
dilutions of aqueous extracts of fruits, 
seeds, stem, root and leaves of E. 
officinalis. In vitro, quantitative, 
antibacterial activity assay was carried out 
by well diffusion assay (12). Mueller-
Hinton Agar (MHA) was used as base 
medium for screening of antibacterial 
activity. About 15 to 20 ml of MHA 
medium was poured in sterile Petri dishes 
and allowed to solidify. In this method, 
wells of diameter 6 mm were dug out 
using a sterile cork borer in solidified 
MHA medium. Using sterile cotton swab, 
0.2 ml of 24 hr old cultures of S. aureus 
and E. coli were inoculated evenly on to 
the surface of the MHA plate to make a 
lawn culture. Dilutions were made from 
the crude extracts that were used for the 
well diffusion assay. From the dilutions 5, 
10, 15, 20, 25 and 30 µl each of the 
various extracts were added to the 
respectively labelled wells. The plates 
were incubated at 37 °C for 24 hrs and 
observed for zone of inhibition of growth 
around the wells. 
 
Zone Analysis and Determination of 
MIC 
The wells were checked for zone of 
clearance around it.  The antibacterial 
activity of the extracts was assayed by 
measuring the diameter of zone of 
inhibition around the wells. The minimum 
concentration of the respective extract 
inhibiting the growth of E. coli and S. 
aureus, around the wells, were taken as the 
minimum inhibitory concentration or MIC.  
 
Study, Observations and Results 
Emblica officinalis Gaertn. is a 
plant of great medicinal importance and 
has been extensively used as antipyretic, 
analgesic and immunomodulatory agent. It 
has antimicrobial activity; potentially 
against various bacterial, viral and fungal 
pathogens. Early studies have reported the 
identification of bioactive compounds in E. 
officinalis (10,1). The potent antibacterial 
activity E. officinalis  against E. coli, K. 
pneumonia, K. ozaenae, Proteus mirabilis, 
P. aeruginosa, S. paratyphi A and S. 
paratyphi B and Serratia marcescens has 
been reported previously (13). The 
bioactive compounds in the entire plant of 
E. officinalis, from aqueous extracts of 
stem, leaf, fruit and seed were evaluated 
for antibacterial activity against pathogenic 
bacterial strains belonging to Gram-
positive and Gram-negative bacteria, 
represented by S. aureus and E. coli, 
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respectively. Here the in vitro antibacterial 
activity of extracts of E. officinalis were 
assayed alone, and also in comparison with 
the extracts from various plant parts.  
 
Table 1.  Dilutions Prepared from Crude Extracts of Fruits, Seeds, Leaves and Stem of 
Emblica officinalis for MIC assay 
Extract Used Dilutions Prepared From the Crude Extracts  
Dilution Used  
in µl 
(Extract/Solvent) 
Quantity at which 
Zone was obtained 
(µl) 
Average Diameter of 
Zone of Inhibition 
in mm 
Aqueous Extract of 
Fruits 
25/100 15 9 
10/100 15 8 
Aqueous Extract of 
Stem 
Crude extract 
(no dilution) 
20 10 
Crude extract 
(No dilution) 
15 9 
Aqueous Extract of 
Leaves 
20/100 10 12 
5/100 5 8 
Aqueous Extract of 
Seeds 
20/100 25 9 
10/100 15 9 
      Diameter of the Well = 6 mm 
 
In this study the bioactive compounds present in the fruits, seeds, stem, roots and 
leaves of E. officinalis were extracted out in water from which dilutions were prepared and 
aliquots of 5, 10, 15, 20, 25 and 30 µl of the dilutions were assayed quantitatively by well 
diffusion method (Table 1). Both the test bacteria viz. E. coli and S. aureus were sensitive to 
the aqueous extracts of the plant parts such as fruit, seed, stem and leaves (Table 2). The root 
extracts, on the contrary, produced no zone of inhibition of growth (0 mm) of bacteria around 
the wells (unpublished). The root extract was not used in the study further since it was not 
inhibitory to the growth of any of the bacterial species used in the assay. 
 
Table 2.  Comparative Antibacterial Activity of Fruits, Seeds, Leaves and Stem Extracts 
of Emblica officinalis Against Gram-Positive and Gram-Negative Bacteria 
 
 
Extract Used 
Quantitative Assay  and MIC  
Organism Used MIC (µg of Original Crude 
Extract)  
Aqueous Extract of Fruits E. coli 3.75 
S.  aureus 1.5 
Aqueous Extract of Stem E. coli 20.0 
S.  aureus 15.0 
Aqueous Extract of Leaves E. coli 1.0 
S.  aureus 0.1 
Aqueous Extract of Seeds E. coli 5.0 
S.  aureus 1.5 
           Diameter of the Well = 6 mm 
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In this study, the lowest MIC was 
recorded for the leaf extracts for both E. 
coli and S. aureus, having inhibition zones 
around wells containing 1.0 µg and 0.1 µg 
of the extracts, respectively (Table 2). 
Stem had the least activity as indicated by 
the MIC of 20 and 15 µg, respectively, for 
E. coli and S. aureus. Fruit and seed 
extracts were similar in their activity 
against E. coli and S. aureus. The MIC for 
fruit and seed extracts against E. coli were 
3.75 and 5 µg, respectively. For the fruit 
and seed extract the MIC values against E. 
coli and S. aureus were 1.5 µg each (Table 
2). 
 
Discussion 
The present study evaluated the 
bioactive compounds in the entire plant of 
Emblica officinalis, from aqueous extracts 
of stem, leaves, fruits and seeds for 
antibacterial activity against E. coli (Gram-
negative bacteria) and S. aureus (Gram-
positive bacteria). The antibacterial 
activity of extracts of E. officinalis bark, 
leaves and fruits has been assayed 
previously by Dhale and Mogle (14), 
where they observed significant 
bactericidal activity of  alcohol extracts of 
Emblica leaves against S. aureus at 20 
mg/ml concentrations, followed by B. 
subtilis, E. coli and P. aeruginosa. The 
least activity of bark has been reportedly 
against E. coli whereas the maximum was 
recorded against S. aureus (10 mg/ml) for 
petroleum ether extracts. In their study the 
fruit extracts also exhibited superior 
activity against S. aureus, at a 
concentration of 20 mg/ml. The current 
study also revealed similar results where 
the entire extracts of Emblica, except of 
root, inhibited the growth of S. aureus 
more, than that of E. coli. The bioactive 
compounds in leaves had maximal activity 
against S. aureus (Table 2) because the 
leaf extract inhibited the bacterial growth 
at the most minimum concentration of 0.1 
µg. The decoctions extracted out of stem 
of E. officinalis had the least activity 
against both Gram-positive S. aureus and 
Gram-negative E. coli though S. aureus 
was more sensitive than E. coli (Table 2). 
Dhale and Mogle (14), in a similar 
study, has also reported the superior 
activity of solvent extracts of leaves, fruits 
and bark of E. officinalis against  the 
Gram-positive  S. aureus, than the Gram-
negative P. aeruginosa and E. coli. Patil et 
al (1) has observed that aqueous extract of 
fruits of E. officinalis were antibacterial to 
the maximum against S. aureus whereas 
the acetone and methanol extracts of fruits 
had maximal antibacterial activity against 
E. coli and K. pneumonia, respectively.  
The current study revealed that the 
aqueous extracts of fruits and seeds were 
equally inhibitory to the growth of S. 
aureus, an inhibitory concentration of 1.5 
µg each, even though the fruit extract 
inhibited the growth of E. coli more 
effectively than the seed extract (Table 2). 
Venkanna and Estari (15) have 
reported lowest MIC values for methanolic 
fractions of Phyllanthus emblica against S. 
aureus (0.08 ml/g) and for P. aeruginosa 
(0.08 ml/g). The antibacterial activity of 
Emblica against Gram-positive and Gram-
negative bacteria by Reghu and Ravindra 
(16) has revealed it to be inhibitorier to S. 
aureus (MIC of 0.261 for methanol 
extract, 0.432 for chloroform extract and 
0.512 for diethyl ether extract) than to K. 
pneumonia (0.342 for methanol extract, 
0.542 for chloroform extract and 0.612 for 
diethyl extract). It could also be concluded 
from the present study that irrespective of 
the plant part used, the extracts were 
superiorly inhibiting the growth of S. 
aureus than to E. coli 
Saeed and Tariq (17) has observed 
effective activity of E. officinalis against a 
range of bacteria including S. aureus, S. 
hemolyticus, S. saprophyticus, 
Micrococcus varians, Bacillus subtilis and 
also against the yeast Candida albicans, 
the maximum of which was exhibited 
against S. typhi. Khanna and Nag (18) 
have also observed that E. officinalis is 
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active against S. aureus, E. coli, M. 
tuberculosis, S. typhosa and Candida 
albicans. Synergistic antibacterial activity 
of E. officinalis seeds against S. aureus in 
combination with Nymphaea odorata 
stamens have been reported earlier (19). It 
is apparent from the quantitative assay in 
this study that the aqueous extracts of E. 
officinalis had maximal antibacterial 
activity, as evidenced by the minimum 
inhibitory concentrations (MIC) against S. 
aureus, i.e., against Gram-positive bacteria 
than Gram-negative E. coli. Similar 
observation has also been reported by 
Saeed and Tariq (17), Venkanna and Estari 
(15) and Reghu and Ravindra (16). 
However the superiority of E. officinalis 
against Gram-positive bacteria has hitherto 
not been reported. 
 
Conclusion 
The bactericidal activity of E. 
officinalis has been attributed to the 
bioactive compounds present in E. 
officinalis namely flavonoids, phenols, 
saponins, and tannins such as emblicanin 
A and B. The present study is a 
preliminary level investigation on the 
comparative analysis of the antibacterial 
activity of the fruits fruits, seeds, stem, 
root and leaves of E. officinalis Gaertn. 
against Gram-positive and Gram-negative 
bacteria. The experimental evidences 
revealed that the aqueous extracts of all the 
samples except root of E. officinalis had 
more antibacterial activity against Gram-
positive bacteria than Gram-negative 
bacteria, producing wider zones of 
inhibition of growth around S. aureus than 
E. coli. The root extract neither inhibited 
the growth of S. aureus nor E. coli. These 
results have to be further confirmed by 
extending the studies to more number of 
Gram-positive and Gram-negative 
bacterial strains. The bioactive compounds 
have to be assayed individually, at the 
same time, selectively, for their activity 
against Gram-positive and Gram-negative 
bacteria.  
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